Arcellx Correlations
| ACLX Stock | USD 113.76 0.01 0.01% |
The current 90-days correlation between Arcellx and Alkermes Plc is 0.12 (i.e., Average diversification). The correlation of Arcellx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Arcellx Correlation With Market
Very good diversification
The correlation between Arcellx and DJI is -0.22 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Arcellx Stock
Moving against Arcellx Stock
| 0.56 | DXB | Dimerix | PairCorr |
| 0.44 | VERA | Vera Therapeutics | PairCorr |
| 0.4 | 9OF | BIORESTORATTHERAPDL | PairCorr |
| 0.38 | HDP1 | Arrowhead Pharmaceuticals | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Arcellx Stock performing well and Arcellx Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Arcellx's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ALKS | 1.56 | 0.01 | 0.02 | 0.11 | 1.91 | 3.73 | 11.25 | |||
| NAMS | 2.24 | (0.19) | 0.00 | (0.17) | 0.00 | 4.20 | 10.21 | |||
| AKRO | 1.14 | 0.32 | 0.19 | 5.81 | 0.63 | 3.29 | 16.73 | |||
| PTGX | 1.61 | 0.00 | (0.02) | 0.10 | 2.05 | 3.36 | 8.01 | |||
| ARWR | 3.29 | 0.64 | 0.20 | 0.50 | 2.86 | 10.85 | 32.02 | |||
| KYMR | 2.79 | 0.62 | 0.18 | 3.85 | 2.49 | 4.40 | 49.42 | |||
| VKTX | 2.91 | (0.12) | 0.00 | (0.08) | 0.00 | 8.18 | 22.96 | |||
| IMVT | 2.17 | 0.15 | 0.07 | 0.22 | 2.33 | 4.47 | 15.37 | |||
| CRSP | 2.62 | (0.02) | 0.02 | 0.09 | 3.05 | 6.23 | 19.81 | |||
| PCVX | 2.33 | 0.31 | 0.13 | 0.37 | 2.24 | 6.20 | 12.67 |
Arcellx Corporate Management
| Helen Kim | VP Affairs | Profile | |
| Michael MBA | Chief Officer | Profile | |
| Kate Aiken | Chief Officer | Profile | |
| Michelle Gilson | Chief Officer | Profile | |
| Myesha Lacy | Chief Officer | Profile | |
| Christopher MD | Chief Officer | Profile | |
| Narinderjeet MS | Chief Officer | Profile |